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Before Protein Modeling

Initially, drugs were discovered by either chance or by trial and error through screening
methods. Because scientists did not have the ability to model protein structures, drug
discovery was a very expensive process. Currently, researchers are working on technologies
to determine protein ligands and potential drugs through the usage of predicted protein
structures.

Ligand-Steering Model2

Docking for determining ligands experimentally models a protein structure
without the presence of ligands. However, the Ligand-Steering Model
(LSM) incorporates the structures of ligands into the predicted protein
structure. Addition of ligands, to complete a protein structure, are modeled
after preexisting proteins. Compared to other traditional methods of
determining similarities, such as homology modeling, the LSM is shown to
be more accurate in its protein prediction in its unliganded state.

Structure Prediction to Target Parasitic Diseases1

● The main difficulty in creating drugs for parasitic diseases is developing a drug that will
target parasitic proteins without affecting host proteins.
● Protein structure prediction can help ease this issue. By determining structural
differences between active enzymes in the parasite and host, researchers can create
inhibitors that specifically target the parasite’s proteins.
● This idea has been implemented for targeting the dihydrofolate reductase-thymidylate
synthase (DHFR-TS) enzyme which is present in 6 different types of parasites. (See
Figure 4).

Docking for Determining Ligands1

One method for structure-based drug design is docking. By using the structure of the
protein’s activation site, a program can determine the ligand shape needed.

“About the Docking@Home Science,” (2009). Docking Home. Retrieved from http://
docktest.cis.udel.edu/about/science/

Figure 4. In blue is the protein DHFR. In
yellow is the ligand for the protein, and in
red is the ligand created by a program
called GOLD.

Figure 2. Ligand and protein structures are combined in order
to create a more accurate protein model.

Modeling G-Protein Coupled Receptors (GPCRs)1
Breda, A., Valadares, N.F., de Souza, O.N., Garratt, R.C. (14 September 2007) “Protein Structure, Modelling and
Applications” Bioinformatics in Tropical Disease Research: A Practical and Case-Study Approach [Internet]. Retreived
from http://www.ncbi.nlm.nih.gov/books/NBK6824/

Background Information:

Figure 1. Representation of how a docking program called DOCK
determines the ligand. After determining the binding site, the program
calculates spheres to associate with the binding site. Ligand atoms
later replace the spheres.

Characteristics of a Good Docking Program
● Takes in count of flexibility of the protein, ligand, and
binding site
● has good scoring functions
○ enables the docking program to quickly sort through
ligand positions that do not work
● Fast virtual screening for large drug analyses

“Biodetection of hCG Hormone,” (2012). iGEM. Retrieved from http://
2012.igem.org/Team:Chalmers-Gothenburg/Theory

Figure 3. GPCR in its inactive and active
states.

● Over a third of all FDA-approved drugs target GPCRs.
● There are more than 800 GPCR genes expressed in
humans
● Modeling GPCRs has been challenging through x-ray
crystallography.
○ only 16 unique class A GPCRs have been modeled
so far

Advances in Modeling
● Can now model complexes between small molecules and GCPRs if the transmembrane domain of
the GPCR is mover 35% homologous to another GPCR.
○ This means that researchers are able to model around 20% of nonolfactory class A GPCRs.
● Protein-ligand modeling has also been advancing.
○ For example, the binding between the H4 receptor and its ligand has successfully been modeled.
○ Modeling protein-ligand interactions can enable researchers to better understand the effects of
ligand mutations.
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